Low Doses of Methylmercury Induce the Proliferation of Thyroid Cells In Vitro Through Modulation of ERK Pathway
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Exposure to environmental endocrine disruptors has been associated with an increased frequency of thyroid pathology. In this study, we evaluated the effects of various concentrations of methylmercury (MeHg) on immortalized, non-tumorigenic thyroid cells (Nthy-ori-3-1). Exposure to MeHg at 2.5 and 5 µM for 24 h caused a reduction in cell viability with a decrease of the cell population in sub-G0 phase, as detected by MTT and flow cytometry. Conversely, MeHg at the lower concentration of 0.1 µM increased the cell viability with a rise of G2/M phase. An immunoblot analysis showed higher expression levels of phospho-ERK and not of phospho-Akt. Further enhancement of the cell growth rate was observed after a prolonged exposure of the cells up to 18 days to MeHg 0.1 µM. The present findings demonstrate the toxicity of high concentrations of MeHg on thyroid cells, while showing that treatment with lower doses of Hg, as may occur after prolonged exposure to this environmental contaminant, exerts a promoting effect on thyroid cell proliferation, by acting on the ERK-mediated pro-oncogenic signal transduction pathway.
Elucidating the link between thyroid cancer and mercury exposure: a review and meta-analysis.
Webster A, Pinion D, Pineda E, Aboueisha H, Hussein M, Fawzy M Environ Sci Pollut Res Int. 2024; 31(9):12841-12855.
PMID: 38273084 PMC: 10881592. DOI: 10.1007/s11356-024-32031-8.
Palomar A, Quinonero A, Medina-Laver Y, Gonzalez-Martin R, Perez-Deben S, Alama P Int J Mol Sci. 2023; 24(10).
PMID: 37240143 PMC: 10218493. DOI: 10.3390/ijms24108799.
Association between metal(loid)s in serum and leukemia: a systematic review and meta-analysis.
Shen C, Zhang K, Yang J, Shi J, Yang C, Sun Y J Environ Health Sci Eng. 2023; 21(1):201-213.
PMID: 37159736 PMC: 10163180. DOI: 10.1007/s40201-023-00853-2.
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine.
Celano M, Gagliardi A, Maggisano V, Ambrosio N, Bulotta S, Fresta M Micromachines (Basel). 2022; 13(10).
PMID: 36295933 PMC: 9609127. DOI: 10.3390/mi13101580.
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.
Maggisano V, Capriglione F, Verrienti A, Celano M, Gagliardi A, Bulotta S Biomedicines. 2022; 10(5).
PMID: 35625697 PMC: 9138952. DOI: 10.3390/biomedicines10050961.